반응 #5681

ord-dc7d68fa76f84aebbe68d0076ffab1c1

반응 방정식

Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(O)c3cc(Cl)ccc32)c(C)c1
5-hydroxy-7-chloro-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine
CN(C)c1ccccn1
dimethylaminopyridine
CN(C)c1ccccn1.Cl
dimethylaminopyridine hydrochloride
CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)O
N-benzyloxycarbonyl-L-valine
C(=NC1CCCCC1)=NC1CCCCC1
dicyclohexylcarbodiimide
Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(OC(=O)[C@@H](N)C(C)C)c3cc(Cl)ccc32)c(C)c1
5-L-valyloxy-7-chloro-1-[2-methyl-4-(2-methylbenzoylamino)-benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine
수율 38.5%

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    workup.STIRRINGthe mixture is stirred at room temperature for 30 minutes
  2. 2
    기타The insoluble materials are removed by filtration
  3. 3
    workup.ADDITIONto the filtrate is added 5% aqueous sodium hydrogen sulfate solution
  4. 4
    추출further extracted with dichloromethane
  5. 5
    세척The extract is washed successively with saturated aqueous sodium hydrogen carbonate solution and saturated brine
  6. 6
    건조dried over magnesium sulfate
  7. 7
    workup.DISTILLATIONthe solvent is distilled off under reduced pressure
  8. 8
    기타to give crude 5-N-benzyloxycarbonyl-L-valyloxy-7-chloro-1-[2-methyl-4-(2-methylbenzoylamino)-benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine (2.0 g)
  9. 9
    기타is subjected to hydrogenation at ordinary room temperature under atmospheric pressure
  10. 10
    기타After hydrogenation, the catalyst is removed by filtration
  11. 11
    농축the filtrate is concentrated
  12. 12
    기타The resulting residue is purified by silica gel column chromatography (eluent; ethyl acetate)

실험 절차

To a solution of 5-hydroxy-7-chloro-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine (1.0 g), dimethylaminopyridine (1.26 g) and dimethylaminopyridine hydrochloride (1.10 g) in chloroform (20 ml) are added N-benzyloxycarbonyl-L-valine (672 mg) and dicyclohexylcarbodiimide (1.42 g), and the mixture is stirred at room temperature for 7 hours. To the mixture are added methanol (3 ml) and acetic acid (0.7 ml), and the mixture is stirred at room temperature for 30 minutes. The insoluble materials are removed by filtration, and to the filtrate is added 5% aqueous sodium hydrogen sulfate solution, and further extracted with dichloromethane. The extract is washed successively with saturated aqueous sodium hydrogen carbonate solution and saturated brine, dried over magnesium sulfate, and the solvent is distilled off under reduced pressure to give crude 5-N-benzyloxycarbonyl-L-valyloxy-7-chloro-1-[2-methyl-4-(2-methylbenzoylamino)-benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine (2.0 g). This product is dissolved in a mixture of acetic acid (15 ml) and ethyl acetate (15 ml), and thereto is added 5% Pd-C (0.3 g). The mixture is subjected to hydrogenation at ordinary room temperature under atmospheric pressure. After hydrogenation, the catalyst is removed by filtration, and the filtrate is concentrated. The resulting residue is purified by silica gel column chromatography (eluent; ethyl acetate) to give Isomer A (0.48 g) and Isomer B (0.47 g) of 5-L-valyloxy-7-chloro-1-[2-methyl-4-(2-methylbenzoylamino)-benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine.

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US05244898uspto-grants-1993_09